NeuroRx plans to file for emergency use authorization (EUA) for Zyesami after the drug has successfully demonstrated a 10-day accelerated recovery from respiratory failure patients that have critical COVID-19 and have been treated with high-flow nasal oxygen. “We look forward to reporting the final 60-day efficacy data shortly,” Dr. Jonathan Javitt, the NeuroRx CEO said […]

William J. Newell has served as our Chief Executive Officer and a member of our Board of Directors since January 2009. Previously, he served as the President of Aerovance, Inc., a biotechnology company focused on respiratory diseases, from 2006 to 2007. Mr. Newell has also served as the Chief Business Officer and Senior Vice President […]

January kicked off with a flurry of SPACs, or special-purpose acquisition companies, and financial experts believe that these financing vehicles will continue to gain steam, with some targeting medtech. Jonas Grossman, president and managing partner of Chardan Investment Bank, which focuses on disruption and innovation in the health care technology space, said that 2020 was […]